Sign In
Buy VRTX
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
3 Healthcare Stocks With the Most Durable Competitive Moats
04:05am, Thursday, 23'rd Apr 2026
These companies offer a clear path to sustained earnings growth.
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
10:01am, Tuesday, 21'st Apr 2026
Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.
Merit Financial Group LLC Buys 2,880 Shares of Vertex Pharmaceuticals Incorporated $VRTX
05:29am, Monday, 20'th Apr 2026
Merit Financial Group LLC lifted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 47.3% during the undefined quarter, according to its most recent filing with the Securities and E
Davidson Investment Advisors Grows Holdings in Vertex Pharmaceuticals Incorporated $VRTX
04:28am, Monday, 20'th Apr 2026
Davidson Investment Advisors boosted its position in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 2.9% in the fourth quarter, according to its most recent filing with the SEC. The institution
2 Under-the-Radar Biotech Stocks Worth Buying for the Long Term
09:45am, Sunday, 19'th Apr 2026
Vertex Pharmaceuticals has shown steady financial growth. Mirum Pharmaceuticals is getting closer to being profitable.
Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to Know
06:51pm, Friday, 17'th Apr 2026
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $441.2, representing a +1.27% change from its previous close.
Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade
07:00pm, Thursday, 16'th Apr 2026
In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $435.65, indicating a -1.37% shift from the previous trading day.
Is Vertex Pharmaceuticals' Empire in Trouble?
03:26pm, Thursday, 16'th Apr 2026
Vertex Pharmaceuticals' business will suffer if other drugmakers launch competing cystic fibrosis drugs. Despite this threat, Vertex Pharmaceuticals' core franchise looks safe for the foreseeable futu
Choreo LLC Grows Position in Vertex Pharmaceuticals Incorporated $VRTX
04:15am, Tuesday, 14'th Apr 2026
Choreo LLC boosted its stake in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 19.7% during the undefined quarter, according to the company in its most recent filing with the Securities and Exc
Trump's Team Says Don't Worry About Rising Inflation. Here Are 3 Stocks to Buy If They're Wrong.
03:45am, Tuesday, 14'th Apr 2026
NextEra Energy operates the largest electric utility in the U.S. Vertex Pharmaceuticals markets therapies for treating cystic fibrosis and other diseases. Walmart is the world's largest consumer stapl
BIP Wealth LLC Takes $551,000 Position in Vertex Pharmaceuticals Incorporated $VRTX
03:30am, Friday, 10'th Apr 2026
BIP Wealth LLC purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) during the fourth quarter, according to the company in its most recent 13F filing with the Securiti
Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider
07:00pm, Wednesday, 08'th Apr 2026
Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $443.92, signifying a +2.79% move from its prior day's close.
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Wednesday, 08'th Apr 2026
Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Vertex to Announce First Quarter 2026 Financial Results on May 4th
04:00pm, Monday, 06'th Apr 2026
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2026 financial results on Monday, May 4, 2026, after the financial markets close. The company
Perpetual Ltd Buys New Shares in Vertex Pharmaceuticals Incorporated $VRTX
06:05am, Monday, 06'th Apr 2026
Perpetual Ltd bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) during the undefined quarter, according to its most recent filing with the Securities and Exchange C
